1 |
Clonidine |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
2 |
Clonidine hcl cf 0,150 mg, tabletten |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
3 |
Clonidine hydrochloride |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
4 |
Device: clonidine (catapressan) |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
5 |
Procedure: arginine and clonidine stimulation testing |
Arginine |
[3] D00281 D00281, D00604 D00604, D02982 D02982 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |